Prime Medicine, Inc. (PRME) was able to release positive data in using its Prime Editing technology therapy PM359 to treat one patient with Chronic Granulomatous Disease [CGD]. The patient was noted ...
Chronic Granulomatous Disease (CGD) is a rare, inherited immunodeficiency caused by mutations in one or more components of the NADPH oxidase complex. This defect compromises the ability of phagocytes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results